Blood cancers

Targeted therapy in CLL: the dawn of a new era

Sponsored by AbbVie Pty Ltd

Chronic lymphocytic leukaemia (CLL) has traditionally been one of the most challenging leukaemias for clinicians to manage.1 Treatment options have been evolving for decades, and never faster than right now.2 To reflect upon the age of chemotherapy to chemo-immunotherapy and now targeted therapy, the limbic sat down with Professor John Seymour, Co-Director of the Division ...

Already a member?

Login to keep reading.

© 2021 the limbic